Prevention of perinatal infection and its consequences in pregnant women

Authors

  • Ю. В. Давыдова Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine, Ukraine

DOI:

https://doi.org/10.18370/2309-4117.2013.11.17-35

Keywords:

perinatal infections, pregnancy, intrauterine infection

Abstract

Perinatal infections today are a major cause of pregnancy disorders and fetus and newborn birth abnormalities. In the majority cases there are no treatment with proven efficacy for perinatal infections or there is no sense to do it during pregnancy. Most perinatal infections are not requiring hospitalization of pregnant or mothers isolated. Pregnant woman should be hospitalized if only it is impossible to carry out patient treatment. The vast majority of perinatal infections (other than HIV infection and acute period of highly contagious diseases) are not a contraindication to breastfeeding.

Author Biography

Ю. В. Давыдова, Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine

MD, head of the department of obstetric problems extragenital

References

  1. Naber K., Bergman B., Bishop M., Bjerklund-Johansen T., Botto H., Lobel B., Jimenez-Cruz F., Selvaggi F.Treatment of sex transm infections in man. Eur. Urol. As. guidance. Eur Urol 2001; 40: 576-588.
  2. Rahangdale L., Guerry S., Bauer H. M. et al.An observational cohort study of Chlamydia trachomatis treatment in pregnancy // Sex Transm Dis. 2006; 33: 106-10.
  3. Centers for Disease Control and Prevention.Sexually Transmitted Diseases Treatment Guidelines. 2006 // MMWR. 2006; 55 (№ RR-11).
  4. Brocklehurst P.Antibiotics for gonorrhoea in pregnancy. Cochrane Database of Systematic Reviews 2007, Issue 4.
  5. Farrell E, Pattinson RC. Antibiotic treatment for syphilis during pregnancy: Commentary BRZ (2002). Library reproductive health WHO, Geneva: Word Health Organization.
  6. Rorman E, Zamir CS, Rilkis I, Ben-David H. Congenital toxoplasmosis-prenatal aspects of Toxoplasma gondii infection. Reprod Toxicol. 2006 May; 21(4): 458-72.
  7. Mandelbrot L. Prevention of mother-to-child transmission of toxoplasmosis. Gynecol Obstet Fertil. 2012 Oct; 40(10): 591-8.
  8. Ergenoрlu AM, Yeniel AO, Yildirim N, Kazandi M, Akercan F, Saрol S. Rubella vaccination during the preconception period or in pregnancy and perinatal and fetal outcomes. Turk J Pediatr. 2012 May-Jun; 54(3): 230-3.
  9. National Guideline for the Management of Genital Herpes. British Association for Sexual Health and HIV.
  10. Polilli E, Parruti G, D’Arcangelo F, Tracanna E, Clerico L, Savini V, D’Antonio F, Rosati M, Manzoli L, D’Antonio D, Nigro G. A preliminary evaluation of safety and efficacy of standard intravenous immunoglobulins in pregnant women with primary Cytomegalovirus infection. Clin Vaccine Immunol. 2012, Oct 24.
  11. Johnson J, Anderson B, Pass RF. Prevention of maternal and congenital cytomegalovirus infection. Clin Obstet Gynecol. 2012 Jun; 55(2): 521-30.
  12. Visentin S, Manara R, Milanese L, Da Roit A, Forner G, Salviato E, Citton V, Magno FM, Orzan E, Morando C, Cusinato R, Mengoli C, Palu G, Ermani M, Rinaldi R, Cosmi E, Gussetti N.Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clin Infect Dis. 2012 Aug; 55(4): 497-503.
  13. Dempsey AF, Pangborn HM, Prosser LA. Cost-effectiveness of routine vaccination of a dolescent females against cytomegalovirus. Vaccine. 2012 Jun 8; 30(27): 4060-6.
  14. The management of varicella-zoster virus exposure and infection in pregnancy and the newborn period. Australasian Subgroup in Paediatric Infectious Diseases of the Australasian Society for Infectious Diseases. Med J Aust. 2001 Mar 19; 174(6): 288-92.
  15. Johansen JS, Westergren T, Lingaas E. Post-exposure varicella prophylaxis. Tidsskr Nor Laegeforen. 2011 Sep 6; 131(17): 1645-8.
  16. Benshushan A, Tsafrir A, Arbel R, Rahav G, Ariel I, Rojansky N. Listeria infection during pregnancy: a 10 year experience. Isr Med Assoc J. 2002 Oct; 4(10): 776-8
  17. Forna F, Gоlmezoglu AM. Interventions for treating trichomoniasis in women (Cochrane Review). In: The Cochrane Library, Update Software: Oxford. Issue 4, 2002.
  18. Gоlmezoglu AM. Interventions for trichomoniasis in pregnancy. Cochrane Database of Systematic Reviews 2007, Issue 4.
  19. Walker G. Methods of trichomoniasis treatment in pregnant women: Comment. BRZ (2004). WHO Library of reproductive health, Geneva: Word Health Organization.
  20. Thinkhamrop J. Antibiotics for bacterial vaginosis treatment in pregnant women: Comment. BRZ (2007). WHO Library of reproductive health, Geneva: Word Health Organization.
  21. Sungkar A, Purwosunu Y, Aziz MF, Pratomo H, Sutrisna B, Sekizawa A.Influence of early self-diagnosis and treatment of bacterial vaginosis on preterm birth rate. Int J Gynaecol Obstet. 2012 Jun; 117(3): 264-7.
  22. Lamont RF, Taylor-Robinson D, Bassett P. Rescreening for abnormal vaginal flora in pregnancy and re-treating with clindamycin vaginal cream significantly increases cure and improvement rates. Int J STD AIDS. 2012 Aug; 23(8): 565-9.
  23. Thomas B. Fitzpatrick, Richard Allen Johnson, Klaus Wolff, Machiel K. Polano, Dick Suurmond. Color Atlas and Synopses of Clinical Dermatology, 3d edition. McGraw-Hill International (UK) Ltd., 1999.
  24. Emery S, Neuhaus JA, Phillips AN et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART Study. J Infect Dis 2008; 197: 1133-1144.
  25. Georg M. Lauer, Bruce D. Walker. Hepatitis C Virus Infection. Vol.345: 41-52, July 5, 2001, No.1.
  26. Guidelines for the Management of Herpes Simplex Virus in Pregnancy. Society of Obstetricians and Gynaecologists of Canada, 2008.
  27. Jules L. Dienstag. Hepatitis B Virus Infection. New England Journal of Medicine, Vol.359: 1486-1500, October 2, 2008, No.14.
  28. Brocklehurst P, Kinghorn G, Carney O, Helsen K, Ross E, Ellis E, et al. A randomised placebo controlled trial of suppressive acyclovir in latepregnancy in women with recurrent suppressive genital herpes infection. Br J Obstet Gynaecol 1998; 105: 275.
  29. Sheffield JS, Hill JB, Hollier LM, Laibl VR, Roberts SW, Sanchez PJ, et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Obstet Gynecol 2006; 108: 141-7.
  30. Tyring SK, Douglas JM Jr, Corey L, Spruance SL, Esmann J. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group. Arch Dermatol. 1998 Feb; 134(2): 185-91.
  31. Newell Marie-Louise, McIntyre James Congenital and perinatal infections prevention, diagnosis and treatment.Cambridge University Press, 2000.
  32. Yeung С, King SM, Roberts EA Mother-to-infant transmission of hepatitis C virus.Hepatology, 2001; 34; 223–229.
  33. Clinical protocol for obstetric care «Perinatal infections».Annex to the Order of the Ministry of Health of Ukraine No. 906 on 27.12.2006.
  34. Oganyan KA, Zatsyorskaya SL, Arzhanova AN, Savicheva AM.Effect of Streptococcus group B, colonizing the urogenital tract of pregnant women on pregnancy course and outcomes. – St. Petersburg.
  35. Nikonov AP, Chylova RA, Ostroumovа MV, Stetsyuk OU, Andreeva IV.Actual treatment of chlamydia infection in pregnant women // Colloquium. – 2010. – № 3.
  36. Losevа ОC. Modern methods for diagnosis, therapy and prevention of STIs and others urogenital infections. – M., 2011.
  37. Protocol of care for pregnant women suffering from syphilis.Annex to the Order of the Ministry of Health of Ukraine No. 312 of 08.05.2009.
  38. Clinical protocol for obstetric care «Prevention of HIV transmission from mother to child». Annex to the Order of the Ministry of Health of Ukraine No. 716 on 14.11.2007.
  39. Clinical protocol antiretroviral therapy of pregnant women. Annex to the Order of the Ministry of Health of Ukraine No. 206 of 07.04.2006.
  40. Dzutseva F. Toxoplasmosis and pregnancy // Medical newspaper. – 2004. – № 82.
  41. Gnatko AP. Valavir (valacyclovir) efficiency in the treatment of genital herpes in women. – Dissertation Summary. – Kyiv.
  42. Pirogovа VI. Reproductive health and ingenious herpes - disputes // Women Health. – 2005. – № 2 (22). – P. 159-161.
  43. Dubchak AE. Problems of viral recurrent infections in the program of pregravid care in infertile women. – K., 2011.
  44. Yatsyk V., Odynaeva ND, Belyaeva IA. Cytomegalovirus infections. Pediatrician Practice // For doctors help. – 2009. – P. 5-12.
  45. Clinical Protocol «Management of pregnant women with chronic hepatitis». Annex to the Order of the Ministry of Health of Ukraine No. 676 of 31.12.2004.
  46. Karapetyan T.E., Nashletashvyly IV, Tyutyunnik VL. Vulvovaginal candidiasis: Modern glance at the problem // Rus. Med. J. – 2011. – № 1. – P. 64-67.
  47. Egorova AT, Bazyna MI, Ruleva MA, Shemanaeva TV. Evaluation of the therapy effectiveness of bacterial vaginitis in pregnant women // Gynecology. – 2011. – № 2, T. 13.
  48. Kovinko LV, Katoninа SL, Petravchuk LV, et al. Actual Problems of perinatology based on analysis of infant mortality in the Kiev city in 2002-2003 // Contemporary Pediatrics. – 2004. – № 3. – P. 11-15.

Downloads

Published

2014-11-15

How to Cite

Давыдова, Ю. В. (2014). Prevention of perinatal infection and its consequences in pregnant women. REPRODUCTIVE ENDOCRINOLOGY, (11), 17–35. https://doi.org/10.18370/2309-4117.2013.11.17-35

Issue

No. 11 (2013)

Section

Analytical review

License

Copyright (c) 2014 Ю. В. Давыдова

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.